Snowball logo
logo
RGNX_logo

REGENXBIO Inc

RGNX β€’ NASDAQ
$6.58-$0.10Β  (1.5%)
πŸ’‘ Click on a row in the table to make it appear on the graph
πŸ“Š Compare financials of multiple companies on the same chart
This feature is available with our premium plans. Upgrade to unlock the full potential of Snowball Analytics and be on top of your investments!
20212022202320242025TTM
Revenue
Total revenue
470.3112.790.2483.33170.4174.5
COGS
51.8354.5537.2133.5720.379.87
Gross Profit
418.558.1853.0349.76150.194.61
Operating Expenses & Income
Operating Income
160(262.9)(268.1)(233.3)(161.2)(164.1)
Total Operating Expenses
258.5321.1321.2283.1311.3258.8
R&D Expenses
181.4242.5232.3208.5228.3229.1
Selling General & Admin Expenses
79.3385.2888.4976.6282.8685.56
Earnings from Continuing Operations
Interest Expense
(26.28)(23.25)(6.862)(12.66)(45.01)(41.95)
Interest Income
0.7190.3420.2430.1740.0830.07
Income Tax Expense
13.41(0.084)(0.152)---
Net Income
Net Income
127.8(280.3)(263.5)(227.1)(193.9)(196.4)
Supplemental
EBIT
167.5(257.2)(256.8)(214.4)(148.9)(154.5)
EBITDA
177.1(244.2)(239.5)(198.2)(133.3)(139.1)
In millions of USD, except % and values per 1 share